Clinical Trial Update: Effects of PH3 in Diabetic Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PH3 for diabetic nephropathy has completed; the provided information does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• PH3

Snippet

Sponsor: PhytoHealth Corporation | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED